MedTrace Logo

Combination Chemotherapy in Treating Patients With Colon Cancer

NCT00046995 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which schedule of chemotherapy is most effective in treating colon cancer.

PURPOSE: Randomized phase III trial to compare different schedules of chemotherapy using carboplatin with fluorouracil and leucovorin in treating patients who have stage IIB or stage III colon cancer.

Conditions

Interventions

DRUG

carboplatin

DRUG

fluorouracil

DRUG

leucovorin calcium

PROCEDURE

adjuvant therapy

Sponsors & Collaborators

  • Groupe Regional d'Etudes du Cancer Colorectal

    lead OTHER

Principal Investigators

  • Christian N.J. Focan, MD, PhD · Clinique Saint-Joseph

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00046995 on ClinicalTrials.gov